GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

APAC deal activity drops 12% YoY in H1 2026 amid M&A and PE slump, reveals GlobalData

Asia-Pacific (APAC) deal activity experienced a year-on-year (YoY) decline of around 12% in the first half (H1) of 2026 as sharp declines in mergers and acquisitions (M&A) and private equity (PE) outweighed modest growth in venture financing. Uneven performance across major markets also highlights diverging deal momentum, with investors and strategic buyers becoming increasingly selective […]
Read more

South Korea’s UGV mass production answers manpower problem, not technology gap, says GlobalData

South Korea’s Defense Acquisition Program Administration selected Hanwha Aerospace’s Arion-SMET in July 2026 as the contractor for its first mass-produced multipurpose unmanned ground vehicle (UGV), marking a significant shift in military modernization. Rather than addressing a technology gap, the program is primarily designed to offset the country’s rapidly shrinking conscription pool by replacing critical squad-level […]
Read more

AI infrastructure boom shifts from chip race to supply chain race, says GlobalData

AI infrastructure spending has entered a new phase, with demand outpacing semiconductors, memory and power capacity despite record earnings across the technology ecosystem. This earnings season reveals that capital investment, geopolitics and supply-chain resilience, not compute demand alone, are increasingly determining the pace of AI deployment, reshaping competitive dynamics across the global semiconductor value chain, […]
Read more

European drug manufacturers under threat from proposed US supply chain bill, says GlobalData

US efforts to scrutinize overseas pharmaceutical manufacturing could expose Europe’s dominant role in supplying FDA-approved innovator and biosimilar drugs, reshaping global biopharma supply chains. Analysis indicates Germany faces the greatest commercial risk as Washington pursues onshoring policies that may trigger tariff and non-tariff measures, creating fresh investment, manufacturing, and market access challenges for pharmaceutical companies […]
Read more

Cell and gene therapy manufacturers turn to specialist automation partners, says GlobalData

Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies. Recent collaborations between developers, contract development and manufacturing organizations (CDMOs), and automation companies demonstrate how robotics, digital systems, and advanced manufacturing platforms are being integrated into production workflows to support more scalable and efficient manufacturing, […]
Read more

GlobalData Healthcare intelligence now available directly inside Claude through Model Context Protocol (MCP)

LONDON, 30 July 2026: GlobalData Healthcare, the pharmaceutical and life sciences intelligence arm of GlobalData Plc, today announced that its proprietary intelligence datasets are now accessible directly inside Claude, Anthropic’s AI assistant, ChatGPT and Gemini, through GlobalData’s Data MCP. Integrations with Microsoft Copilot and Perplexity follow as part of the same rollout, giving pharma, biotech […]
Read more

Niktimvo approval in Australia reinforces momentum for macrophage-targeted cGVHD therapies, says GlobalData

Australia’s Therapeutic Goods Administration (TGA) approved Niktimvo (axatilimab) for chronic graft-versus-host disease (cGVHD) in May 2026, making Australia the first market outside the US to authorize the therapy. The decision strengthens the role of macrophage-targeted treatments for heavily pretreated patients, while highlighting reimbursement, real-world adoption, and earlier-line evidence as key factors shaping its long-term clinical […]
Read more

Underwriting remains top AI use case for insurers as enterprise-wide adoption accelerates, reveals GlobalData

Artificial intelligence (AI) is expanding its role across the insurance value chain as insurers increasingly move beyond its traditional use in underwriting. Growing confidence in AI is driving adoption in product development, customer service, claims management, and other core functions, reflecting a broader shift from isolated use cases towards enterprise-wide transformation aimed at improving efficiency, […]
Read more

Specialty coffee brews a mainstream opportunity across retail, foodservice and packaging, says GlobalData

Speciality coffee, a fast-growing segment within premium beverages, is gaining prominence across retail, foodservice, and packaging space, evolving from an artisanal niche into a mainstream lifestyle-led category. This is driven by converging consumer demand for premium quality, personalization, functional wellness, ethical sourcing, and sustainable packaging. Brands are increasingly using specialty coffee, which is defined single-origin […]
Read more

MASH market growth in India hinges on awareness-led strategies, says GlobalData

Non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) market in India is entering a new phase, with awareness-driven strategies expected to play a pivotal role in improving diagnosis, treatment access, and patient outcomes. The expanded approval of semaglutide for adults with MASH and fibrosis stages F2–F3 marks a significant development, while rising diagnosed prevalence and growing awareness initiatives […]
Read more

Spain insulin pumps market to grow at 8% CAGR through 2036, forecasts GlobalData

Spain’s insulin pumps market is expected to witness steady growth, driven by the increasing prevalence of type 1 diabetes, growing adoption of advanced diabetes management technologies, and rising demand for automated insulin delivery systems. The shift toward personalized, data-driven diabetes care, supported by continuous glucose monitoring (CGM) integration and smart insulin delivery technologies, is accelerating […]
Read more

Europe digital health market to grow at 6% CAGR through 2035, forecasts GlobalData

The adoption of AI-powered digital health solutions in the treatment of cancer is shaping the oncology landscape by supporting earlier cancer detection and improving diagnostic precision throughout the patient care journey. As these solutions become increasingly integrated into routine clinical practice, they are expected to play a pivotal role in advancing the digital transformation of […]
Read more

GlobalData adopts Model Context Protocol (MCP) to embed intelligence directly inside enterprise workflows

LONDON, 21 July 2026 – GlobalData Plc, the leading intelligence and productivity platform, today announced the adoption of the Model Context Protocol (MCP) across its data and AI products. The move lets enterprise AI systems and agents connect to GlobalData’s proprietary intelligence through secure, governed integrations, taking GlobalData from a platform you visit to intelligence […]
Read more

Paul, Weiss, Rifkind, Wharton & Garrison and Kirkland & Ellis top M&A legal advisers in technology, media and telecom sector during H1 2026, reveals GlobalData

Paul, Weiss, Rifkind, Wharton & Garrison and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the technology, media and telecom (TMT) sector during the first half (H1) of 2026 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading intelligence and productivity platform. […]
Read more

Morgan Stanley and Houlihan Lokey top M&A financial advisers in technology, media and telecom sector during H1 2026, reveals GlobalData     

Morgan Stanley and Houlihan Lokey were the top mergers and acquisitions (M&A) financial advisers in the technology, media and telecom (TMT) sector during the first half (H1) of 2026 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading intelligence and productivity platform. An analysis of GlobalData’s Financial […]
Read more

Sullivan & Cromwell and Skadden, Arps, Slate, Meagher & Flom top M&A legal advisers in South & Central America during H1 2026, reveals GlobalData

Sullivan & Cromwell and Skadden, Arps, Slate, Meagher & Flom were the top mergers and acquisitions (M&A) legal advisers in South & Central America during the first half (H1) of 2026 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading intelligence and productivity platform. An analysis of […]
Read more

Goldman Sachs top M&A financial adviser in South & Central America during H1 2026, reveals GlobalData

Goldman Sachs was the top mergers and acquisitions (M&A) financial adviser in South & Central America during the first half (H1) of 2026 by both value and volume, according to the latest financial advisers league table by  GlobalData, a leading intelligence and productivity platform. An analysis of GlobalData’s Financial Deals Database reveals that Goldman Sachs […]
Read more
1 2 3 4 206